Atea Pharmaceuticals AVIR
NASDAQ AVIR
$5.18 -0.02 (-0.38%)
At close: Sep 29, 2026 · 4:00 PM EDT

Atea Pharmaceuticals (AVIR) Share-based Compensation (2019 - 2026)

Updated

Atea Pharmaceuticals' Share-based Compensation was $3.38 million in Q2 2026, down 27.6% from $4.67 million a year earlier and down 9.3% from the prior quarter.

Analysis

Atea Pharmaceuticals (AVIR) Share-based Compensation (2019 - 2026) Analysis & Trends

On a trailing twelve-month basis, Atea Pharmaceuticals' Share-based Compensation was $16.21 million through Jun 30, 2026, down 57.4% year-over-year; for FY2025, it was $20.72 million, down 60.0% from FY2024.

  • Share-based Compensation shows a five-year compound annual growth rate of 22.7% (FY2020 to FY2025).
  • In earlier years, Share-based Compensation was $51.77 million in FY2024 (+4.7%), $49.43 million in FY2023 (+5.8%), $46.72 million in FY2022 (+17.9%) and $39.62 million in FY2021 (+431.3%).
  • The Q2 2026 figure marks the lowest quarterly Share-based Compensation since Q4 2020.
  • Compared with a year earlier, Share-based Compensation has declined for six straight quarters, with an average decline of 37.1% over the last eight quarters.
  • The best year-over-year quarter for Share-based Compensation over five years was Q4 2021 (growth of 302.4%); the worst was Q4 2025 (a decline of 67.9%).
  • Per Business Quant data, AVIR's Share-based Compensation in the three quarters before Q2 2026 was $3.73 million (Q1 2026), $4.59 million (Q4 2025) and $4.52 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 458.00 Mn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 166.00 Mn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 298.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 165.00 Mn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 231.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 249.00 Mn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 170.20 Mn
10 Atea Pharmaceuticals 417.06 Mn 417.06 Mn - 3.38 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.38 Mn
Mar 31, 2026 3.73 Mn
Dec 31, 2025 4.59 Mn
Sep 30, 2025 4.52 Mn
Jun 30, 2025 4.67 Mn
Mar 31, 2025 6.95 Mn
Dec 31, 2024 14.30 Mn
Sep 30, 2024 12.16 Mn
Jun 30, 2024 12.72 Mn
Mar 31, 2024 12.59 Mn
Dec 31, 2023 12.16 Mn
Sep 30, 2023 12.38 Mn
Jun 30, 2023 12.35 Mn
Mar 31, 2023 12.54 Mn
Dec 31, 2022 11.65 Mn
Sep 30, 2022 11.50 Mn
Jun 30, 2022 11.91 Mn
Mar 31, 2022 11.66 Mn
Dec 31, 2021 11.35 Mn
Sep 30, 2021 10.99 Mn
API Access

Atea Pharmaceuticals Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=AVIR&period=max&api_key=YOUR_API_KEY